Strides Arcolab receives USFDA’s nod for Bangalore facility

MUMBAI, Jan 31: Pharma major, Strides Arcolab Ltd said that that the company’s oral dosage facility at KRS Gardens in Bangalore has been found acceptable by the US Food and Drug Administration (USFDA).

The inspection was carried out in August 2014, company said in a filing with BSE.

This facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets.

The manufacturing plant supports important current and future submissions for the US Market

(AGENCIES)